IT1398291B1 - Ferro bisglicinato chelato per uso nel trattamento per via orale dell'anemia in pazienti celiaci. - Google Patents

Ferro bisglicinato chelato per uso nel trattamento per via orale dell'anemia in pazienti celiaci.

Info

Publication number
IT1398291B1
IT1398291B1 ITMI2009A002198A ITMI20092198A IT1398291B1 IT 1398291 B1 IT1398291 B1 IT 1398291B1 IT MI2009A002198 A ITMI2009A002198 A IT MI2009A002198A IT MI20092198 A ITMI20092198 A IT MI20092198A IT 1398291 B1 IT1398291 B1 IT 1398291B1
Authority
IT
Italy
Prior art keywords
bisglycinate
chelated
anemia
iron
oral treatment
Prior art date
Application number
ITMI2009A002198A
Other languages
English (en)
Inventor
Claudio Aldo Ame
Massimo Baldacci
Original Assignee
Baldacci Lab Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baldacci Lab Spa filed Critical Baldacci Lab Spa
Priority to ITMI2009A002198A priority Critical patent/IT1398291B1/it
Priority to EP20100192857 priority patent/EP2338495A1/en
Priority to EP20140175516 priority patent/EP2799074A1/en
Priority to BRPI1005537-1A priority patent/BRPI1005537A2/pt
Priority to RU2010151631/15A priority patent/RU2541092C2/ru
Publication of ITMI20092198A1 publication Critical patent/ITMI20092198A1/it
Application granted granted Critical
Publication of IT1398291B1 publication Critical patent/IT1398291B1/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/26—Iron; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ITMI2009A002198A 2009-12-16 2009-12-16 Ferro bisglicinato chelato per uso nel trattamento per via orale dell'anemia in pazienti celiaci. IT1398291B1 (it)

Priority Applications (5)

Application Number Priority Date Filing Date Title
ITMI2009A002198A IT1398291B1 (it) 2009-12-16 2009-12-16 Ferro bisglicinato chelato per uso nel trattamento per via orale dell'anemia in pazienti celiaci.
EP20100192857 EP2338495A1 (en) 2009-12-16 2010-11-29 Iron bis-glycinate chelate for use in the oral treatment of anemia in patients with celiac disease
EP20140175516 EP2799074A1 (en) 2009-12-16 2010-11-29 Iron bis-glycinate chelate for use in the oral treatment of anemia in patients with celiac disease
BRPI1005537-1A BRPI1005537A2 (pt) 2009-12-16 2010-12-15 quelato de bis-glicinato de ferro
RU2010151631/15A RU2541092C2 (ru) 2009-12-16 2010-12-15 Бисглицинат-хелат железа для использования в пероральном лечении анемии у пациентов с целиакией

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI2009A002198A IT1398291B1 (it) 2009-12-16 2009-12-16 Ferro bisglicinato chelato per uso nel trattamento per via orale dell'anemia in pazienti celiaci.

Publications (2)

Publication Number Publication Date
ITMI20092198A1 ITMI20092198A1 (it) 2011-06-17
IT1398291B1 true IT1398291B1 (it) 2013-02-22

Family

ID=42034516

Family Applications (1)

Application Number Title Priority Date Filing Date
ITMI2009A002198A IT1398291B1 (it) 2009-12-16 2009-12-16 Ferro bisglicinato chelato per uso nel trattamento per via orale dell'anemia in pazienti celiaci.

Country Status (4)

Country Link
EP (2) EP2799074A1 (it)
BR (1) BRPI1005537A2 (it)
IT (1) IT1398291B1 (it)
RU (1) RU2541092C2 (it)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2849732C (en) * 2011-09-22 2019-10-01 Jonathan Bortz Buffered upper gi absorption promoter
ITMI20121750A1 (it) * 2012-10-16 2014-04-17 Baldacci Lab Spa Ferro bisglicinato chelato per uso nel trattamento dell'anemia
TWI483721B (zh) * 2013-09-05 2015-05-11 Profeat Biotechnology Co Ltd The use of a composition containing a ferrous amino acid chelate for the manufacture of anti-cancer medicaments
TWI513461B (zh) * 2014-11-25 2015-12-21 Profeat Biotechnology Co Ltd The use of a composition containing a ferrous amino acid chelate for the manufacture of a medicament for improving diabetes mellitus
US11865099B2 (en) 2015-07-17 2024-01-09 Laboratori Baldacci S.P.A. Product based on iron bis-glycinate chelate and alginic acid and/or water-soluble salts thereof, formulations thereof, and pharmaceutical uses thereof
ITUB20152290A1 (it) * 2015-07-17 2017-01-17 Laboratori Baldacci Spa Prodotto a base di ferro bisglicinato chelato e acido alginico e/o suoi sali idrosolubili, sue formulazioni ed suoi usi farmaceutici
CA3118750C (en) * 2018-11-30 2023-08-01 Balchem Corporation Metal complex or metal chelate compositions comprising minimal nanoparticles

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2198665C1 (ru) * 2001-12-27 2003-02-20 Общество с ограниченной ответственностью Фирма "А-БИО" Способ получения железосодержащего лекарственного средства
US20040214885A1 (en) * 2003-04-28 2004-10-28 Hagen Brent P. Ferrous bisglycinate hydrochloride
US20090035385A1 (en) * 2004-12-22 2009-02-05 Drugtech Corporation Compositions including iron
ITMI20071979A1 (it) * 2007-10-12 2009-04-13 Massimo Baldacci Formulazioni farmaceutiche contenenti ferro bisglicinato chelato

Also Published As

Publication number Publication date
RU2010151631A (ru) 2012-06-20
ITMI20092198A1 (it) 2011-06-17
RU2541092C2 (ru) 2015-02-10
EP2799074A1 (en) 2014-11-05
BRPI1005537A2 (pt) 2013-04-09
EP2338495A1 (en) 2011-06-29

Similar Documents

Publication Publication Date Title
LTC2937350I2 (lt) 1'-pakeistieji karba-nukleozidų analogai, skirti antivirusiniam gydymui
IT1398291B1 (it) Ferro bisglicinato chelato per uso nel trattamento per via orale dell'anemia in pazienti celiaci.
SMT201600025B (it) Composti di isoindolina per l'uso nel trattamento del cancro
EP2382176A4 (en) USE OF CURCUMIN ANALOGUES CONTAINING NITROGEN FOR THE TREATMENT OF ALZHEIMER'S DISEASE
EP1876990A4 (en) DENTAL TREATMENT THROUGH ALIGNMENT ELEMENTS
HUE059861T2 (hu) N-Szubsztituált 2,5-dioxo-azolin vegyületek a rák kezelésében való felhasználásra
BRPI0918023A2 (pt) composição oral, e, método para melhorar a saúde bucal de um usuário
MX2012001974A (es) Compuestos de biarilo y metodos de uso de los mismos.
SMT201700014B (it) Agenti terapeutici per la riduzione dei livelli dell'ormone paratiroideo
EA201170753A1 (ru) Налмефена гидрохлорид дигидрат
AU324215S (en) Handpiece for massage or therapy
IL211313A0 (en) Compounds, compositions and methods for the treatment of ??-amyloid diseases and synucleinopathies
EP2331520A4 (en) ROSAMINE DERIVATIVES AS AGENTS FOR CANCER TREATMENT
ZA201005116B (en) 6.7-dialkoxy ouinazoline derivatives useful for treatment of cancer related disorders
BRPI0810774A2 (pt) composição de cuidado oral ou cuidado corporal.
MX2010006206A (es) Derivados de oxindol substituidos por 5-halogeno y el uso de los mismos para el tratamiento de enfermedades dependientes de la vasopresina.
BRPI1007603A2 (pt) "composição de tratamento do cabelo"
ZA201101303B (en) Kit for the treatment of onychomycosis
EA201200190A1 (ru) Фулвестрант в дозе 500 мг для лечения распространенного рака молочной железы
ATE544455T1 (de) Zusammensetzungen und verfahren für die krebsbehandlung
IL207668A0 (en) Beloxepin, its enantiomers, and analogs thereof for the treatment of pain
PL2036575T3 (pl) Kompozycje farmaceutyczne do stosowania doustnie w leczeniu pacjentów dotkniętych otyłością
FR2940121B1 (fr) Composition pour le soin de la peau
IT1397522B1 (it) Uso di una combinazione per il trattamento dell'osteoartrosi
MX2009011214A (es) Uso de 4-ciclopropilmetoxi-n-(3,5-dicloro-1-oxido-4-piridin-4-il)- 5-(metoxi)piridin-2-carboxamida para el tratamiento de los traumatismos craneales.